Common TitleiPrEx Subgroup Analysis in Transgender Women
Official Title HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
Phase Phase III
Treatments
Tenofovir DF-Emtricitabine
Tenofovir DF-Emtricitabine
Tradename:Truvada and Multiple GenericsOther Names:TDF-FTC, Tenofovir disoproxil fumarate-EmtricitabineClass:Nucleoside Reverse Transcriptase Inhibitors (NRTI)Categories PREP
Funding
IndustryGilead Sciences
Non-IndustryBill & Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases (NIAID)
References
- Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2:e512-9.